Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

• Main Authors: Zembutsu, Hitoshi, Nakamura, Seigo, Akashi-Tanaka, Sadako, Kuwayama, Takashi, Watanabe, Chie, Takamaru, Tomoko, Takei, Hiroyuki, Ishikawa, Takashi, Miyahara, Kana, Matsumoto, Hiroshi, Hasegawa, Yoshie, Kutomi, Goro, Shima, Hiroaki, Satomi, Fukino, Okazaki, Minoru, Zaha, Hisamitsu, Onomura, Mai, Matsukata, Ayami, Sagara, Yasuaki, Baba, Shinichi, Yamada, Akimitsu, Shimada, Kazuhiro, Shimizu, Daisuke, Tsugawa, Koichiro, Shimo, Arata, Tan, Ern Yu, Hartman, Mikael, Chan, Ching-Wan, Lee, Soo Chin, Nakamura, Yusuke
• Other Authors: MEDICINE
• Format: Article
• Language: English
• Published: AMER ASSOC CANCER RESEARCH 2021
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; PATIENTS RECEIVING TAMOXIFEN; KI-67 LABELING INDEX; ADJUVANT TAMOXIFEN; GENETIC POLYMORPHISMS; POSTMENOPAUSAL WOMEN; CLINICAL-OUTCOMES; ESTROGEN-RECEPTOR; ACTIVE METABOLITE; GENOTYPE; ASSOCIATION
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/209297
• Institution: National University of Singapore

CLINICAL CANCER RESEARCH